Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
nesuparib (JPI-547)
i
Other names:
JPI-547, JPI 547, NOV 1402, NOV140201, NOIU1402, ONC-201
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(7)
News
Trials
Company:
Jeil
Drug class:
PARP inhibitor, TNKS inhibitor
Related drugs:
‹
olaparib (342)
talazoparib (81)
niraparib (80)
rucaparib (71)
ABT-888 (35)
pamiparib (18)
fluzoparib (12)
IMP4297 (6)
NOV 1401 (3)
SC10914 (2)
ABT-767 (1)
SBP-101 (1)
AMXI-5001 (0)
AZD2461 (0)
E7016 (0)
HWH340 (0)
TSL1502 (0)
[²¹¹At]PTT (0)
kt-3000 series (0)
kt-3283 (0)
SMOCL-9112 (0)
2X-121 (0)
G007-LK (1)
MSC2504877 (1)
XAV-939 (1)
STP1002 (1)
olaparib (342)
talazoparib (81)
niraparib (80)
rucaparib (71)
ABT-888 (35)
pamiparib (18)
fluzoparib (12)
IMP4297 (6)
NOV 1401 (3)
SC10914 (2)
ABT-767 (1)
SBP-101 (1)
AMXI-5001 (0)
AZD2461 (0)
E7016 (0)
HWH340 (0)
TSL1502 (0)
[²¹¹At]PTT (0)
kt-3000 series (0)
kt-3283 (0)
SMOCL-9112 (0)
2X-121 (0)
G007-LK (1)
MSC2504877 (1)
XAV-939 (1)
STP1002 (1)
›
Associations
(7)
News
Trials
VERI cancer hierarchy
Reset Filters
BRCA1 mutation
Ovarian Cancer
BRCA1 mutation
Ovarian Cancer
JPI-547
Sensitive: C2 – Inclusion Criteria
JPI-547
Sensitive
:
C2
JPI-547
Sensitive: C2 – Inclusion Criteria
JPI-547
Sensitive
:
C2
BRCA2 mutation
Non Small Cell Lung Cancer
BRCA2 mutation
Non Small Cell Lung Cancer
JPI-547
Sensitive: C4 – Case Studies
JPI-547
Sensitive
:
C4
JPI-547
Sensitive: C4 – Case Studies
JPI-547
Sensitive
:
C4
ATM mutation
Breast Cancer
ATM mutation
Breast Cancer
JPI-547
Sensitive: C4 – Case Studies
JPI-547
Sensitive
:
C4
JPI-547
Sensitive: C4 – Case Studies
JPI-547
Sensitive
:
C4
BRCA2 mutation
Breast Cancer
BRCA2 mutation
Breast Cancer
JPI-547
Sensitive: C4 – Case Studies
JPI-547
Sensitive
:
C4
JPI-547
Sensitive: C4 – Case Studies
JPI-547
Sensitive
:
C4
BRCA1 mutation
Breast Cancer
BRCA1 mutation
Breast Cancer
JPI-547
Sensitive: C4 – Case Studies
JPI-547
Sensitive
:
C4
JPI-547
Sensitive: C4 – Case Studies
JPI-547
Sensitive
:
C4
HRD
Pancreatic Ductal Adenocarcinoma
HRD
Pancreatic Ductal Adenocarcinoma
JPI-547
Sensitive: D – Preclinical
JPI-547
Sensitive
:
D
JPI-547
Sensitive: D – Preclinical
JPI-547
Sensitive
:
D
RNF43 mutation
Pancreatic Ductal Adenocarcinoma
RNF43 mutation
Pancreatic Ductal Adenocarcinoma
JPI-547
Sensitive: D – Preclinical
JPI-547
Sensitive
:
D
JPI-547
Sensitive: D – Preclinical
JPI-547
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login